HSIC
64
5
HPQ
46
2
MMC
53
-2
WHR
51
-2
AAP
18
-15
MCK
60
-2
BSX
52
-2
COP
45
-2
UNP
48
-4
IRM
44
3
O
48
-2
FOXA
59
2
MAC
62
2
KSS
62
3
EOG
50
-4
NSC
57
-3
STT
73
2
HST
43
-9
SPG
55
4
HUM
31
-4
HSIC
64
5
HPQ
46
2
MMC
53
-2
WHR
51
-2
AAP
18
-15
MCK
60
-2
BSX
52
-2
COP
45
-2
UNP
48
-4
IRM
44
3
O
48
-2
FOXA
59
2
MAC
62
2
KSS
62
3
EOG
50
-4
NSC
57
-3
STT
73
2
HST
43
-9
SPG
55
4
HUM
31
-4
Financhill
Back

Strategy, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
37

MSTR
Strategy, Inc.

Last Price:
$184.56
Seasonality Move:
16.83%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Sell
37
Strategy, Inc. (MSTR) is a Sell

Is Strategy, Inc. a Buy, Sell or Hold?

  • The current Strategy, Inc. [MSTR] share price is $188.99. The Score for MSTR is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • MSTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

MSTR Stock Price Chart

What is Strategy, Inc.'s stock price today?

  • The Strategy, Inc. share price today is $188.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSTR is experiencing slight selling pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

MSTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -19.41 Sell
Relative Strength Index (14 RSI): 40.76 Sell
Chaikin Money Flow: -446390 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (173.43 - 226.85) Sell
Bollinger Bands (100): (233.84 - 377.18) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

MSTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 182 Buy
20-day SMA: 189.17 Sell
50-day SMA: 251.93 Sell
200-day SMA: 328.79 Sell
8-day EMA: 184.03 Buy
20-day EMA: 196.56 Sell
50-day EMA: 239.17 Sell
200-day EMA: 299.4 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

Strategy, Inc. Earnings Growth & MSTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $65.78 per share, and an increase next year of $14.78 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

Strategy, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):